The current price of WST is $401.40 — it has increased by 2.27% since the previous close. Data as of Nov 6, 2026.
WST is down 4.22% over the past week, up 7.72% over the past month and up 45.78% over the past year. The price is above its 200-day moving average of $316.23.
Analysts' average 12-month price target for WST is $427.43, which implies 6.49% upside from the current price. Individual estimates range from $390.00 to $475.00.
Of the 16 analysts covering West Pharmaceutical Services, Inc., 3 rate it a strong buy, 12 rate it a buy and 1 rates it a strong sell. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
West Pharmaceutical Services, Inc. has a market capitalization of $27.96B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, West Pharmaceutical Services, Inc. posted earnings of $2.66 per share against an estimate of $2.20, beating expectations by 20.91%. Upcoming reports are listed in the earnings calendar.
West Pharmaceutical Services, Inc. reported revenue of $874.5M in its most recent quarter, which has increased by 8.73% compared with the same quarter a year earlier. Analysts had expected $827.12M.
Yes. West Pharmaceutical Services, Inc. pays dividends quarterly. The latest payment of $0.26 per share has a payment date of Nov 18, 2026, which corresponds to a dividend yield of 0.23%.
Companies most comparable to West Pharmaceutical Services, Inc. include Sartorius AG ADR, Sartorius Stedim Biotech S.A., AptarGroup, Inc., ICU Medical, Inc. and Stevanato Group S.p.A.
In the latest trading session WST moved between $386.88 and $402.40, a range of 3.87% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of West Pharmaceutical Services, Inc. shows a buy rating today and a strong buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for West Pharmaceutical Services, Inc. is buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks WST has traded between $223.83 and $438.27. The current price is 8.41% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.